BlackRock
TERN

BlackRock’s Terns Pharmaceuticals TERN Stock Holding History

BlackRock’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$505M Buy
9,569,585
+1,375,367
+17% +$56.5M 0.01% 1091
2025
Q4 		$331M Buy
8,194,218
+2,642,910
+48% +$61.1M 0.01% 1371
2025
Q3 		$41.7M Buy
5,551,308
+80,934
+1% +$517K ﹤0.01% 2616
2025
Q2 		$20.4M Sell
5,470,374
-236,258
-4% -$738K ﹤0.01% 3012
2025
Q1 		$15.8M Sell
5,706,632
-36,850
-0.6% -$150K ﹤0.01% 3072
2024
Q4 		$31.8M Buy
5,743,482
+1,044,711
+22% +$7.07M ﹤0.01% 2749
2024
Q3 		$39.2M Buy
4,698,771
+578,263
+14% +$4.76M ﹤0.01% 2629
2024
Q2 		$28.1M Buy
4,120,508
+804,979
+24% +$4.88M ﹤0.01% 2775
2024
Q1 		$21.7M Sell
3,315,529
-93,449
-3% -$610K ﹤0.01% 2949
2023
Q4 		$22.1M Buy
3,408,978
+244,163
+8% +$1.29M ﹤0.01% 2958
2023
Q3 		$15.9M Buy
3,164,815
+26,286
+0.8% +$167K ﹤0.01% 3072
2023
Q2 		$27.5M Buy
3,138,529
+2,437,862
+348% +$28.4M ﹤0.01% 2834
2023
Q1 		$8.3M Buy
700,667
+401,229
+134% +$3.83M ﹤0.01% 3414
2022
Q4 		$3.05M Buy
299,438
+13,145
+5% +$87.5K ﹤0.01% 3947
2022
Q3 		$1.69M Buy
286,293
+136,765
+91% +$508K ﹤0.01% 4274
2022
Q2 		$371K Sell
149,528
-587,413
-80% -$1.17M ﹤0.01% 4864
2022
Q1 		$2.19M Sell
736,941
-8,594
-1% -$36.7K ﹤0.01% 4349
2021
Q4 		$5.27M Buy
745,535
+142,979
+24% +$1.19M ﹤0.01% 3975
2021
Q3 		$6.28M Buy
602,556
+164,952
+38% +$1.71M ﹤0.01% 3869
2021
Q2 		$5.37M Buy
437,604
+30,255
+7% +$515K ﹤0.01% 3849
2021
Q1 		$8.96M Buy
+407,349
New +$8.93M ﹤0.01% 3638

Other funds holding TERN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock's TERN Position: Q1 2026 in Review

BlackRock increased its Terns Pharmaceuticals (TERN) stake by 17% in Q1 2026, buying an estimated $56.5M and bringing the position to 9,569,585 shares worth $505M. The position accounts for 0.01% of the portfolio, ranked #1091.

BlackRock first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • BlackRock held 9,569,585 shares of Terns Pharmaceuticals worth $505M as of Q1 2026.
  • BlackRock bought 1,375,367 Terns Pharmaceuticals shares in Q1 2026, an estimated $56.5M.
  • Terns Pharmaceuticals made up 0.01% of BlackRock's portfolio in Q1 2026, its #1091 holding.
  • BlackRock first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.